Skip to main content

Advertisement

Table 2 Baseline characteristics of the parent RCT[23] participants (n = 42 children/adolescents)

From: An exploration of parents’ preferences for foot care in juvenile idiopathic arthritis: a possible role for the discrete choice experiment

Characteristic Value
Demographics
Age (yrs)* 10.1 (3.8)
Male/female (n) 13/29
Body mass index* 19.1
SDS BMI percentiles* 64.5 (0.3)
Disease duration (months)* 46.9 (35.9)
Pharmacological management  
Analgesics: n (%) 5 (12)
NSAIDs: n (%) 5 (12)
Methotrexate: n (%) 32 (76)
Etanercept: n (%) 12 (29)
Sulphasalazine: n (%) 1 (2)
Rituximab: n (%) 1 (2)
Combination methotrexate & etanercept: n (%) 10 (24)
Disease subtypes  
Persistent oligo: n (%) 10 (24)
Extended oligo: n (%) 9 (21)
Poly-: n (%) 15 (36)
Poly+: n (%) 2 (5)
PsA: n (%) 3 (7)
ERA: n (%) 2 (5)
Systemic: n (%) 0 (0)
Undifferentiated: n (%) 1 (2)
  1. *Mean (standard deviation); n, number of participants; SDS, standardised deviation score British 1990 growth reference (UK 90); NSAID, non-steroidal anti-inflammatory drugs; Poly -, polyarthritis rheumatoid factor negative; poly+, polyarthritis rheumatoid factor positive; PsA, psoriatic arthritis; ERA, enthesitis related arthritis.